Interacting Drugs |
Arsenic trioxide vs Toremifene |
Security Level |
|
Mechanism |
Toremifene: QTc-Prolonging Agents may enhance the QTc-prolonging effect of Toremifene. The risk for potentially dangerous arrhythmias may be increased. |
Management |
Avoid combination |
Arsenic trioxide vs Toremifene
Post Review about Arsenic trioxide vs Toremifene Click here to cancel reply.
Other Interactions of Arsenic trioxide
Other Interactions of Toremifene
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.